RGPD3
protein-codingRANBP2 like and GRIP domain containing 3, the group of Tetratricopeptide repeat domain containing
Gene summary
This gene is located in a cluster of Ran-binding protein related genes on chromosome 2 which arose through duplication in primates. The encoded protein contains an N-terminal TPR (tetratricopeptide repeat) domain, two Ran-binding domains, and a C-terminal GRIP domain (golgin-97, RanBP2alpha, Imh1p and p230/golgin-245) domain. [provided by RefSeq, Sep 2011]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~77.1 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
No GenCC data available for this gene.
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to RGPD3 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001144013.2. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 5 | 6 | |||
| missense | 360 | 20 | 380 | |||
| nonsense | 1 | 1 | ||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 2 | 2 | ||||
| Total | 0 | 0 | 364 | 25 | 0 | 389 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001137485.1 | 23 | MANE Select | |
| Ensembl | ENSP00000386588.4 | 23 | MANE Select | |
| Ensembl | ENSP00000303659.8 | 23 | Standard | |
| Ensembl | ENSP00000303659.8 | 23 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- RNA transport - Homo sapiens (human)
Biological Process
- NLS-bearing protein import into nucleus
- positive regulation of GTPase activity
Molecular Function
- GTPase activator activity
- Ran GTPase binding
Cellular Component
- nucleus
- nuclear pore
- cytoplasm
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000409886
- Coding exons
- 23
- Length
- 63387
- Individuals with no LoFs
- 123389
- Homozygous LoFs
- 72
- Heterozygous LoFs
- 2250
- Defined
- 125711
- p
- 0.00928
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -3.42 | 772 | 547 | 1.41 | 0.0000274 | 11240 |
| Missense (PolyPhen) | 166 | 117.88 | 1.4082 | 2380 | ||
| Synonymous | -2.65 | 254 | 206 | 1.23 | 0.0000115 | 3245 |
| Loss of Function | -2.53 | 65 | 46.4 | 1.40 | 0.00000235 | 1057 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.013 | 0.011 | notable |
| Latino/Admixed American | 0.030 | 0.025 | notable |
| Ashkenazi Jewish | 0.00071 | 0.00069 | rare |
| East Asian | 0.0045 | 0.0044 | notable |
| Finnish | 0.0026 | 0.0025 | notable |
| European (Non-Finnish) | 0.0075 | 0.0073 | notable |
| South Asian | 0.010 | 0.0086 | notable |
| Other | 0.0083 | 0.0079 | notable |
dbNSFP Gene Annotations
Source:
Essentials
- Essential (CRISPR)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.0269
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | High |
| Cancer | Medium | Medium | Medium |